NOVEL lymph-node-inspired hydrogels enhance CAR T cell activation and proliferation by 50%, offering a more efficient and ...

Researchers in Canada are developing a low-cost orthovoltage radiotherapy system for use in low-resource and geographically remote regions ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Bristol Myers Squibb (BMS) has announced that its dual immunotherapy combination has been recommended by the National ...

Oral presentation at ASCO to highlight topline Phase 2 data of elraglusib in combination with gemcitabine/nab-paclitaxel (GnP) in first-line treatment of metastatic pancreatic ductal adenocarcinoma ...

Cork University Hospital (CUH) has announced two major innovations in cancer care to 'significantly enhance treatment options ...

Hear the stories from the doctors, scientists and patients at the Arthur J.E. Child Comprehensive Cancer Centre ...

Ingelheim, Germany and Amsterdam, the Netherlands, 23 April 2025 ? Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches ...

Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer.

Zurich-based startup Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, ...

BioSkryb Genomics, a pioneer in single-cell and ultra?low-input multi-omic solutions, and Ultima Genomics, a leader in scalable and cost-effective sequencing, today announced a collaboration designed ...

In a shining moment for Uganda and the African scientific community, Dr Matthias Magoola, founder of Dei Biopharma, has been ...